AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 6, 2023

The key issue is the lack of dedicated guidelines on the disposal under the Drugs & Cosmetics Act. There is a growing concern about the lack of stringent norms on disposal of unused and expired medicines that pose a threat to health and the environment.

Medicine 136

Medicine Cosmetics Drugs Clinical Trials 136

STAT News

MARCH 9, 2023

WASHINGTON — President Biden made lowering drug prices a key part of his budget with proposals to expand Medicare drug price negotiation, squeeze more rebates out of drug companies, and lower the cost of insulin for everyone with insurance. The request made Thursday also details a $7.2

Drugs 98

Drugs Insulin Cosmetics Regulation 98

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 6, 2022

The medical devices industry has urged the Centre to ensure obligation on the part of the buyer or users to purchase or use only those medical devices with required licenses and certifications under the New Drugs, Medical Devices and Cosmetics (NDMDC) Bill, 2022, the draft of which has been circulated by the Union Health Ministry […].

Drugs 128

Drugs Cosmetics Licensing Licensing 128

FDA Law Blog

JULY 7, 2022

While FDASLA focuses on user fees and includes several other provisions regarding drugs and devices, it also includes provisions related to cosmetics. The current House bill does not include the cosmetic provisions and it remains to be seen which riders will survive and which will be eliminated.

Cosmetics 52

Cosmetics Regulation Manufacturing Drugs 52

AuroBlog - Aurous Healthcare Clinical Trials blog

FEBRUARY 13, 2023

Although provisions of the Pharmacy Practice Regulations (PPR) 2015 are not there in the Drugs and Cosmetics (D&C) Act 1940 but are framed under the Pharmacy Act 1948, the steps now being taken by the drugs control administration (DCA) in Tamil Nadu in a motive to strengthen the dispensing activities in pharmacies are completely agreeing […] (..)

Pharmacy 156

Pharmacy Cosmetics Drugs Regulation 156

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 19, 2023

Taking into account the four main components of regulator, industry, trade and patient/consumer in a medicine value supply chain, the Drugs and Cosmetics (D&C) Rules, 1945 and D&C Act, 1940 needs an urgent revamp as there is no clause of compensation for ADRs in patients, according to drug regulatory experts.

Cosmetics 153

Cosmetics Drugs Medicine Regulation 153

Pharmaceutical Technology

MAY 16, 2023

It will benefit from Omega’s newly opened injectable manufacturing facility, which has received clearances from Health Canada and the US Food and Drug Administration, as well as from Juno’s commercial network and product development pipeline.

Allergies 130

Allergies Cosmetics Drugs Vaccination 130

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 21, 2022

The Karnataka drugs control department is insisting that all the cough syrup manufacturers dealing in ethylene glycol and diethylene glycol will now need to procure solvents like glycerin and propylene glycol complying to pharmacopeia standards directly from manufacturers as required under para 10 of the Schedule M of the Drugs & Cosmetics Act, (..)

Cosmetics 162

Cosmetics Drugs Manufacturing Clinical Trials 162

XTalks

SEPTEMBER 14, 2022

Daxxify was FDA-approved for similar cosmetic purposes as Botox and other neuromodulators like Dysport and Xeomin. Many people choose to undergo non-invasive cosmetic procedures to prevent or reduce the appearance of signs of aging. By reducing the movement of these muscles, wrinkles become less pronounced over time.

Botox 98

Botox FDA Approval Clinical Trials Clinical Trials 98

Pharmaceutical Technology

MARCH 30, 2023

The FDA’s proposed FY2024 Budget tops $7bn, to be shared between drug, food, and cosmetics tasks and overheads such as buildings; this is $372m higher than in FY 2023, a 10% increase. Recall powers for all drugs: The budget reveals legislative as well as spending plans; the agency wants to expand its authority to recall any drug.

Contract Manufacturing 147

Contract Manufacturing Manufacturing Pharma Companies Drugs 147

XTalks

JUNE 5, 2023

Ozempic and Wegovy, which contain the active ingredient semaglutide, were approved by the US Food and Drug Administration (FDA). As of May 2023, both Ozempic and Wegovy were on the FDA’s Drug Shortages list due to a global shortage of semaglutide. The approved drugs contain the base form of semaglutide.

FDA Approval 97

FDA Approval Drugs Pharmacy Insulin 97

Drug Discovery World

FEBRUARY 2, 2023

As of late December 2022, the US Food and Drug Administration (FDA) no longer needs drugs to be tested in animals to receive approval, according to legislation signed by President Joe Biden 1 – the Modernization Act 2.0. may not materially change the current drug approval process at the FDA.

Drugs 52

Drugs Clinical Trials Clinical Trials Cosmetics 52

XTalks

JANUARY 25, 2023

Massachusetts-based TheracosBio has received US Food and Drug Administration (FDA) approval for diabetes med Brenzavvy (bexagliflozin) to help improve glycemic control in adults with type 2 diabetes. The drug is taken once a day in conjunction with diet and exercise. What is the Animal Drug Regulatory Process?

FDA Approval 52

FDA Approval Drugs Life Science Clinical Trials 52

Pharmaceutical Technology

SEPTEMBER 29, 2022

Holding a presence in the cosmetic dermatology sector, Curatio’s portfolio comprises more than over 50 brands that are commercialised in India. Curatio has built a commendable set of high market share brands in cosmetic and pediatric dermatology that we look forward to adding to our product offerings.”.

Dermatology 147

Dermatology Cosmetics Scientist Drugs 147

FDA Law Blog

JANUARY 22, 2023

On December 29, 2022, the President signed into law the Food and Drug Omnibus Reform Act of 2022 (“FDORA”) as part of the Consolidated Appropriations Act, 2023 , Pub. FDORA primarily amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act. 117-328 (2022).

Cosmetics 59

Cosmetics Drugs Regulation Production 59

Pharmaceutical Technology

MARCH 1, 2023

According to GlobalData, Phase I drugs for Head And Neck Cancer Squamous Cell Carcinoma have an 80% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Nedisertib’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Gene Editing 100

Gene Editing Clinical Trials Clinical Trials DNA 100

Pharmaceutical Technology

MARCH 1, 2023

According to GlobalData, Phase I drugs for Neuroendocrine Tumors have a 74% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Nedisertib’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Gene Editing 100

Gene Editing Clinical Trials Clinical Trials DNA 100

Pharmaceutical Technology

APRIL 4, 2023

On April 4, Scorpion Therapeutics announced a collaboration and license agreement with the French dermo-cosmetic and pharmaceutical group Pierre Fabre to codevelop two next-generation epidermal growth factor receptor (EGFR) inhibitors. STX-241 and STX-721, both target EGFR mutations in non-small cell lung cancer (NSCLC).

Drugs 130

Drugs Cosmetics Licensing Licensing 130

BioTech 365

AUGUST 3, 2021

Eurofins Strengthens Its Global Leadership Position in Cosmetics and Personal Care Products Testing and Clinical Services and Grows Its Position in Dermatology Drug Testing Eurofins Strengthens Its Global Leadership Position in Cosmetics and Personal Care Products Testing and Clinical Services … Continue reading →

Dermatology 52

Dermatology Cosmetics Drugs Production 52

Pharmacy Checkers

FEBRUARY 12, 2021

With lies and deception, Big Pharma has used the threat posed by rogue websites and counterfeit drugs to push back against U.S. state legislation to gain access to lower drug prices in Canada. Simple summary: Canada’s brand drugs are priced much lower and states want access to them. There’s no gray in that statement.

Drugs 71

Drugs Pharmacy FDA Approval Cosmetics 71

FDA Law Blog

JANUARY 23, 2023

Livornese — Last month, Congress took a big step towards improving clinical trial diversity by requiring sponsors of most drug and device clinical studies to submit a diversity action plan when they submit key trial documents to the Food and Drug Administration (FDA).

Clinical Trials 59

Clinical Trials Clinical Trials Trials Drugs 59

XTalks

MAY 25, 2023

In this episode, Vera talked about the US Food and Drug Administration’s (FDA) approval of Veozah (fezolinetant), the new type of drug for menopausal hot flashes and night sweats. The team discussed Veozah and the benefits of this drug for women’s health. during or after the menopausal transition.

Life Science 52

Life Science Filler FDA Approval Drugs 52

FDA Law Blog

JUNE 2, 2022

Since 1984, generic drugs have been approved under ANDAs pursuant to section 505(j) of the Federal Food, Drug, and Cosmetic Act (FDCA); before 1984, no formal mechanism for an ANDA existed so FDA used sections 505(b) and 505(c) to approve follow-on drugs based on the Agency’s previous findings of safety and efficacy.

Drugs 52

Drugs Generic Drugs Cosmetics Regulation 52

My Local Study

APRIL 28, 2023

Food, Drug, and Cosmetic Act, established in 1938, helped set the standard for research studies today, shaping how medications and treatments are evaluated and released. Since then, clinical trials have expanded to offer groundbreaking opportunities for medical advancements.

Clinical Trials 52

Clinical Trials Clinical Trials Research Cosmetics 52

XTalks

NOVEMBER 14, 2022

In the US, it’s against the law to use the carcinogenic color additive Red 3 in cosmetics, such as lipsticks or blush or topicals. As a result, in 1990, the agency eliminated certain “provisionally listed” uses of the chemical — meaning cosmetics and externally applied drugs. But those steps were never taken.

Scientist 98

Scientist Cosmetics Drugs Containment 98

Pharma Tutor

FEBRUARY 2, 2023

FDA Inspections - Overview admin Thu, 02/02/2023 - 13:52 FDA Inspection is a regulatory process conducted by the United States Food and Drug Administration (FDA) to evaluate the compliance of food and drug establishments with FDA regulations and standards.

Cosmetics 52

Cosmetics Drugs Compliance Regulation 52

Pfizer

DECEMBER 20, 2022

FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for its COVID-19 oral treatment, PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets).

Drugs 69

Drugs Clinical Trials Clinical Trials Medicine 69

Pharmacy Checkers

JUNE 26, 2020

Canada is a good option for Americans seeking to access their medications at a lower cost through personal drug importation , but even I agree with the pharmaceutical industry when they say that wholesale drug importation on a large scale is not workable with Canada. Simply because Canada is too small a nation to supply the U.S.

Drugs 55

Drugs Medicine Vaccination Vaccine 55

The Pharma Data

NOVEMBER 29, 2021

Food and Drug Administration today approved Cytalux (pafolacianine), an imaging drug intended to assist surgeons in identifying ovarian cancer lesions. The drug is designed to improve the ability to locate additional ovarian cancerous tissue that is normally difficult to detect during surgery. Related Information.

FDA Approval 52

FDA Approval Drugs Protein Cosmetics 52

Pharmacy Checkers

OCTOBER 2, 2020

In most cases, the reason is that the same drugs sold in the U.S. million Americans import drugs to save money each year. First, wholesale importation of lower cost drugs from Canada is now lawful. That is pursuant to Section 804 of the Food, Drug and Cosmetic Act. are much cheaper elsewhere.

Drugs 54

Drugs Pharmacy FDA Approval Cosmetics 54

Camargo

SEPTEMBER 8, 2021

Some Drugs May Require Reclassification to Devices. On August 9, the FDA published a Federal Register notice requesting information and comments regarding products currently classified as drugs which may require reclassification as devices. This is in response to the decision from the U.S.

Development 186

Development Drugs Regulation Generic Drugs 186

FDA Law Blog

SEPTEMBER 30, 2021

See Federal Food, Drug, and Cosmetic Act (“FDCA”) Section 503A(b)(2). The matter involves a “decades old skirmish” dating back to the late 1990s, (and previously blogged about here and here ) when Congress passed the Food and Drug Administration Modernization Act (“FDAMA”), which created Section 503A.

Drugs 98

Drugs Pharmacy Regulation Cosmetics 98

The Pharma Data

NOVEMBER 16, 2022

Food and Drug Administration issued advising letters to five enterprises for the unauthorized marketing of 15 differente-cigarette products. is banned under the Federal Food, Drug, and Cosmetic( FD&C) Act. FDA Warns enterprises for Dealing IllegalE-cigarettes That Look Like Toys, Food, and Cartoon Characters. moment, theU.S.

Cosmetics 98

Cosmetics Drugs Manufacturing Vaccination 98

FDA Law Blog

DECEMBER 21, 2022

clinical guidelines); Contextually relevant reference information about a disease or condition; Drug-drug interaction and drug-allergy contraindication notifications to avert adverse drug events; Drug formulary guidelines; Duplicate testing or prescription production prevention notification (e.g.,

Drugs 59

Drugs Allergies Cosmetics Regulation 59

Camargo

NOVEMBER 15, 2021

The 21 st Century Cures Act generated a good deal of excitement and interest when it added a section called “ Utilizing Real World Evidence ” to the Food, Drug, and Cosmetic Act (Section 505F). The FDA recently published the ICH’s Harmonised Guideline Q13, titled “ Continuous Manufacturing of Drug Substances and Drug Products.”

Development 187

Development Drugs Manufacturing FDA Approval 187

FDA Law Blog

SEPTEMBER 15, 2022

Draft Guidance Regarding the Statement of Identity and Strength for Human Nonprescription Drug Products. FDA indicates that this guidance is intended to help manufacturers ensure consistent content and format of the statement of identity and strength for all nonprescription drug products, which then will allow consumers to compare products.

Drugs 45

Drugs Regulation Containment Manufacturing 45

The Pharma Data

NOVEMBER 23, 2021

director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research. Cytomegalovirus infections that are resistant or do not respond to available drugs are of even greater concern. Approval is for Cytomegalovirus, a Type of Herpes Virus. Today, the U.S. Source link: [link].

FDA Approval 52

FDA Approval Drugs DNA Medicine 52